Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC). Azenosertib is being evaluated as a monotherapy and in combination across multiple tumor types in clinical trials and has broad franchise potential. In clinical trials, azenosertib has been well tolerated and has demonstrated anti-tumor activity as a single agent across multiple tumor types. The Company is also leveraging its extensive experience and capabilities to translate its science to advance research on additional areas of opportunity for azenosertib outside PROC. The Sr Director, Clinical Operations is responsible for developing and executing effective clinical operations plans and for overseeing delivery of multiple clinical trials. Maintains quality across the clinical organization, including by developing and managing Standard Operating Procedures and ensuring readiness for health authority inspections. Manages and actively develops a team of clinical operations professionals.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
No Education Listed
Number of Employees
101-250 employees